OUR PRODUCTS

MOBILE APPS

GENERAL INFO

PROK

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

ProKidney (PROK) Earnings Date & Reports

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PROK is expected to report earnings to rise 12.38% to -14 cents per share on November 18

Q3'25

Est.

$-0.15

Q1'25

Beat

by $0.03

Q4'24

Missed

by $0.01

Q3'24

Missed

by $0.01

Q2'24

Beat

by $0.09

The last earnings report on May 12 showed earnings per share of -12 cents, beating the estimate of -15 cents. With 2.35M shares outstanding, the current market capitalization sits at 345.56M.

View a ticker or compare two or three

Compare

PROK

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PROK
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PROK showed earnings on May 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2000 Frontis Plaza Boulevard

Phone

+1 336 999-7028

Employees

163

Web

https://www.prokidney.com